Norway· NO-ID_01D59A53-BB0B-4BEB-BAD1-9032EC3114F2
Ongentys
A opicapone product containing opicapone, registered in Norway by BIAL - Portela & Companhia, S.A. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Opicapone is registered in 14 of 19 countries.
Countries holding a registration under ATC N04BX04 (opicapone), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Opicapone · ATC N04BX04
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of opicapone costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Opicapone · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.01
The record
At a glance
FEST (Norway)- Active substance
- Opicapone
- Manufacturer
- BIAL - Portela & Companhia, S.A
- Country
- Norway (NO)
- ATC code
- N04BX04
- ATC class
- Opicapone
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_01D59A53-BB0B-4BEB-BAD1-9032EC3114F2
- no_varenummer58216530NOK 1134.4
- gtin5600360211150
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
69 interactions on record for opicapone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Opicapone · interactions on record
69 records
- 2 severe
- 67 moderate
Most severe, free to view
- ProcarbazineL01XB01severe
- Methylthioninium chlorideV03AB17severe
- EpinephrineA01AD01moderate
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Opicapone in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainONGENTYS 50 MG CAPSULAS DURASBial Portela & Ca S.A.
- CzechiaONGENTYSBIAL - Portela & Ca., SA, S. Mamede do Coronado
- FinlandOngentysAbacus Medicine A/S
- SwitzerlandOngentys 50 mg, gélulesBial SA
- BelgiumOngentys 50 mgBIAL - Portela & Cª
- United KingdomOngentys 50mg capsulesPharmaram Ltd
- PolandOngentysBIAL - Portela & Ca. SA
- IrelandOngentys 50 mg hard capsulesBIAL-Portela & Ca, S.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ongentys
- Liechtenstein · Ongentys
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d881ede0-c672-427c-ba40-0aac10c03859 GET /v1/drugs/d881ede0-c672-427c-ba40-0aac10c03859?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Opikapon",
"merkevare_id": "ID_01D59A53-BB0B-4BEB-BAD1-9032EC3114F2",
"name_form_strength": "Ongentys kaps 50 mg",
"prescription_group": "C"
}See everything about opicapone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.